Stockscreener 앱 받기
35.23
13.67%
-5.38
전일 마감가:
$40.61
열려 있는:
$35
하루 거래량:
1.46M
Relative Volume:
1.99
시가총액:
$2.05B
수익:
$32.87M
순이익/손실:
$674.31M
주가수익비율:
3.1012
EPS:
11.36
순현금흐름:
$-330.11M
1주 성능:
-8.17%
1개월 성능:
-3.04%
6개월 성능:
+5.00%
1년 성능:
-21.65%
1일 변동 폭
$32.70
$36.19
1주일 범위
$32.70
$41.10
52주 변동 폭
$23.41
$62.58
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
명칭
Agios Pharmaceuticals Inc
전화
617-649-8600
주소
88 SIDNEY STREET, CAMBRIDGE, MA
AGIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals Inc
|
35.20 | 2.28B | 32.87M | 674.31M | -330.11M | 11.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.21 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.00 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.38 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
732.50 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
320.50 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-24 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-27 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-03 | 개시 | Piper Sandler | Overweight |
| 2022-11-17 | 업그레이드 | Goldman | Sell → Neutral |
| 2022-07-27 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-03 | 개시 | BofA Securities | Buy |
| 2021-07-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-07-01 | 개시 | Raymond James | Mkt Perform |
| 2021-06-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-03-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-02-26 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-10-22 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-04 | 개시 | Barclays | Equal Weight |
| 2019-11-26 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-05-23 | 재개 | Goldman | Neutral |
| 2019-02-15 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2018-09-25 | 개시 | Leerink Partners | Mkt Perform |
| 2018-05-23 | 개시 | Citigroup | Buy |
| 2018-04-11 | 재확인 | Credit Suisse | Outperform |
| 2018-02-15 | 재확인 | Needham | Buy |
| 2018-02-15 | 재확인 | SunTrust | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-08-10 | 재확인 | Needham | Buy |
| 2017-08-08 | 재확인 | SunTrust | Buy |
| 2017-08-02 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2017-06-26 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-01-17 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2016-10-24 | 개시 | Needham | Buy |
| 2016-06-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2016-05-18 | 재확인 | SunTrust | Buy |
모두보기
Agios Pharmaceuticals Inc 주식(AGIO)의 최신 뉴스
How to forecast Agios Pharmaceuticals Inc. trends using time seriesM&A Rumor & Fast Entry Momentum Alerts - Newser
Is Agios Pharmaceuticals Inc. undervalued by DCF analysisMarket Sentiment Review & Reliable Momentum Entry Alerts - khodrobank.com
Full technical analysis of Agios Pharmaceuticals Inc. stockBond Market & AI Powered Market Trend Analysis - Newser
Should you wait for a breakout in Agios Pharmaceuticals Inc.2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
Price action breakdown for Agios Pharmaceuticals Inc.Portfolio Value Summary & High Yield Stock Recommendations - Newser
Agios Pharmaceuticals Inc.’s volatility index tracking explained2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - Newser
Long term hold vs stop loss in Agios Pharmaceuticals Inc.Treasury Yields & Daily Chart Pattern Signal Reports - Newser
What MACD signals say about Agios Pharmaceuticals Inc.Weekly Stock Recap & Technical Buy Zone Confirmations - Newser
Developing predictive dashboards with Agios Pharmaceuticals Inc. dataIndex Update & Fast Momentum Entry Tips - Newser
Historical volatility pattern of Agios Pharmaceuticals Inc. visualizedEarnings Growth Summary & Daily Technical Forecast Reports - Newser
Chart Patterns Forming a Bullish Setup in Agios Pharmaceuticals Inc.Sell Signal & Free High Return Stock Watch Alerts - beatles.ru
Can trapped investors hope for a rebound in Agios Pharmaceuticals Inc.Trade Volume Report & Weekly Stock Breakout Alerts - Newser
How to track smart money flows in Agios Pharmaceuticals Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - Newser
Is Agios Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Outlook & Technical Pattern Based Buy Signals - Newser
Can Agios Pharmaceuticals Inc. deliver consistent EPS growthWeekly Stock Recap & Weekly High Return Stock Opportunities - khodrobank.com
Is Agios Pharmaceuticals Inc. a turnaround storyJuly 2025 Summary & High Accuracy Investment Entry Signals - khodrobank.com
Commit To Buy Agios Pharmaceuticals At $30, Earn 34.9% Annualized Using Options - Nasdaq
Detecting support and resistance levels for Agios Pharmaceuticals Inc.Dollar Strength & Fast Moving Stock Trade Plans - Newser
Using AI based signals to follow Agios Pharmaceuticals Inc.Quarterly Trade Review & High Accuracy Trade Alerts - Newser
Is Agios Pharmaceuticals Inc. trending in predictive chart modelsLong Setup & Reliable Breakout Stock Forecasts - Newser
What moving averages say about Agios Pharmaceuticals Inc.Watch List & Safe Capital Investment Plans - Newser
Long term hold vs stop loss in Agios Pharmaceuticals Inc2025 Biggest Moves & Daily Stock Trend Watchlist - Newser
Will Agios Pharmaceuticals Inc. benefit from sector rotation2025 Buyback Activity & AI Powered Market Entry Ideas - khodrobank.com
Earnings Beat: Does Agios Pharmaceuticals Inc. outperform in volatile marketsCPI Data & Daily Risk Controlled Trade Plans - khodrobank.com
Combining machine learning predictions for Agios Pharmaceuticals Inc.2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser
Will Agios Pharmaceuticals Inc. outperform tech stocksTrade Risk Summary & Community Driven Trade Alerts - khodrobank.com
Does Agios Pharmaceuticals Inc. stock reflect fundamentalsWeekly Loss Report & Technical Confirmation Alerts - khodrobank.com
Has Agios Pharmaceuticals Inc. found a price floorMarket Sentiment Review & Precise Buy Zone Identification - Newser
Does Agios Pharmaceuticals Inc. show high probability of rebound2025 Top Gainers & Community Verified Swing Trade Signals - Newser
Chart based exit strategy for Agios Pharmaceuticals Inc.2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
What technical models suggest about Agios Pharmaceuticals Inc.’s comeback - Newser
Is Agios Pharmaceuticals Inc. stock poised for growth2025 Performance Recap & Community Verified Watchlist Alerts - Newser
Published on: 2025-08-31 15:38:48 - Newser
Exit strategy if you’re trapped in Agios Pharmaceuticals Inc.Quarterly Profit Report & AI Optimized Trade Strategies - Newser
Price momentum metrics for Agios Pharmaceuticals Inc. explainedWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Can trapped investors hope for a rebound in Agios Pharmaceuticals IncWeekly Stock Summary & Technical Buy Zone Confirmations - Newser
Agios Pharmaceuticals Inc (AGIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Agios Pharmaceuticals Inc 주식 (AGIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Scadden David | Director |
Aug 27 '25 |
Sale |
40.00 |
200 |
8,000 |
17,603 |
1.13%
0.22%
자본화:
|
볼륨(24시간):